CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
$41.1M |
| 2 |
Darling Ingredients
DAR
|
$37M |
| 3 |
Johnson & Johnson
JNJ
|
$34.5M |
| 4 |
Veru
VERU
|
$34M |
| 5 |
MetLife
MET
|
$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
$46.7M |
| 2 |
Nike
NKE
|
$42.5M |
| 3 |
Illinois Tool Works
ITW
|
$37M |
| 4 |
Gilead Sciences
GILD
|
$32.3M |
| 5 |
Merck
MRK
|
$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
T-Mobile US
TMUS
$284B
| $14.9M | 0.1% |
106,556
-8,698
| -8% | -$1.22M |
|
202
BioAtla
BCAB
$31.5M
| $14.9M | 0.1% |
1,805,406
-105,000
| -5% | -$866K |
|
203
Quest Diagnostics
DGX
$20.5B
| $14.9M | 0.1% |
95,071
+5,489
| +6% | +$859K |
|
204
Becton Dickinson
BDX
$55.1B
| $14.8M | 0.1% |
58,245
-15,089
| -21% | -$3.84M |
|
205
Interpublic Group of Companies
IPG
$9.94B
| $14.7M | 0.1% |
441,883
-209,905
| -32% | -$6.99M |
|
206
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $14.6M | 0.1% |
503,804
+94,518
| +23% | +$2.74M |
|
207
Mid-America Apartment Communities
MAA
$17B
| $14.6M | 0.1% |
92,904
+421
| +0.5% | +$66.1K |
|
208
Arrowhead Research
ARWR
$4.02B
| $14.5M | 0.1% |
358,054
-90,000
| -20% | -$3.65M |
|
|
ITOS
209
DELISTED
iTeos Therapeutics
ITOS
| $14.4M | 0.1% |
739,517
| – | – |
|
210
Apellis Pharmaceuticals
APLS
$3.55B
| $14.4M | 0.1% |
278,507
-65,000
| -19% | -$3.36M |
|
211
Veracyte
VCYT
$2.55B
| $14.3M | 0.1% |
602,146
+223,483
| +59% | +$5.3M |
|
212
Equity Residential
EQR
$25.5B
| $13.9M | 0.09% |
235,581
+155,816
| +195% | +$9.19M |
|
213
LPL Financial
LPLA
$26.6B
| $13.8M | 0.09% |
64,043
+43,760
| +216% | +$9.46M |
|
214
American Tower
AMT
$92.9B
| $13.6M | 0.09% |
64,360
-6,997
| -10% | -$1.48M |
|
215
Zoetis
ZTS
$67.9B
| $13.6M | 0.09% |
92,926
+9,315
| +11% | +$1.37M |
|
216
Arthur J. Gallagher & Co
AJG
$76.7B
| $13.5M | 0.09% |
71,855
-38,392
| -35% | -$7.24M |
|
|
IMGN
217
DELISTED
Immunogen Inc
IMGN
| $13.3M | 0.09% |
2,689,296
-165,339
| -6% | -$820K |
|
218
Charles Schwab
SCHW
$167B
| $13.2M | 0.09% |
159,087
-32,021
| -17% | -$2.67M |
|
219
Axsome Therapeutics
AXSM
$6.25B
| $13.2M | 0.09% |
171,474
+61,094
| +55% | +$4.71M |
|
220
Arcellx
ACLX
$4.03B
| $13.1M | 0.09% |
422,154
+388,931
| +1,171% | +$12M |
|
221
Sun Life Financial
SLF
$32.4B
| $12.9M | 0.09% |
278,757
-54,908
| -16% | -$2.55M |
|
222
Comcast
CMCSA
$125B
| $12.9M | 0.09% |
369,162
-308,415
| -46% | -$10.8M |
|
223
Wabtec
WAB
$33B
| $12.9M | 0.09% |
129,135
-1,639
| -1% | -$164K |
|
224
Kymera Therapeutics
KYMR
$3.11B
| $12.8M | 0.09% |
511,476
-38,142
| -7% | -$952K |
|
225
C.H. Robinson
CHRW
$14.9B
| $12.7M | 0.09% |
138,422
+98,467
| +246% | +$9.02M |
|